Multiple primary cancers (renal papillary, lymphoma and teratoma) and hepatic cysts in association with a pathogenic germline mutation in the MET gene
Author:
- 20 July 2020
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 20 (1) , 81-83
Abstract
Activating germline mutations of the MET gene are associated with hereditary papillary renal cancer. This a very rare autosomal dominant condition, which is usually considered not to display a phenotype of multiple types of malignancy. However, this report describes the case of a man who has been affected with testicular teratoma, diffuse large B-cell lymphoma and multiple hepatic cysts, as well as multiple papillary renal cancers. There is good supporting evidence for roles of over-expression/activity of the HGF/MET ligand-receptor in development of these tumours, raising the possibility of other increased cancer risks associated with activating germline MET gene mutations.Keywords
This publication has 16 references indexed in Scilit:
- MET in human cancer: germline and somatic mutationsAnnals of Translational Medicine, 2017
- The role of HGF/c-MET signaling pathway in lymphomaJournal of Hematology & Oncology, 2016
- Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and ParagangliomasClinical Cancer Research, 2016
- Multilocus Inherited Neoplasia Alleles SyndromeJAMA Oncology, 2016
- Pleiotropic Activities of HGF/c-Met System in Testicular Physiology: Paracrine and Endocrine ImplicationsFrontiers in Endocrinology, 2014
- Retroperitoneal teratoma with somatic malignant transformation: A papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapyBMC Urology, 2013
- Germline Met Mutations in Mice Reveal Mutation- and Background-Associated Differences in Tumor ProfilesPLOS ONE, 2010
- Inhibition of c-MET is a potential therapeutic strategy for treatment of diffuse large B-cell lymphomaLaboratory Investigation, 2010
- The hepatocyte growth factor/ met pathway in development, tumorigenesis, and B-cell differentiation2000
- Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasNature Genetics, 1997